Neonc Technologies (NASDAQ:NTHI) Posts Quarterly Earnings Results

Neonc Technologies (NASDAQ:NTHI) released its earnings results on Friday. The company reported ($0.45) earnings per share (EPS) for the quarter, Zacks reports.

Neonc Technologies Stock Up 1.1%

NASDAQ NTHI traded up $0.10 during trading hours on Friday, hitting $9.08. The company had a trading volume of 69,119 shares, compared to its average volume of 129,146. Neonc Technologies has a fifty-two week low of $3.20 and a fifty-two week high of $25.00. The firm’s 50 day moving average is $10.36 and its 200 day moving average is $7.37.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (e)” rating on shares of Neonc Technologies in a research note on Wednesday, October 8th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, Neonc Technologies presently has a consensus rating of “Sell”.

Institutional Investors Weigh In On Neonc Technologies

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Royal Bank of Canada purchased a new stake in Neonc Technologies during the 1st quarter worth approximately $247,000. Vanguard Group Inc. bought a new stake in shares of Neonc Technologies during the 3rd quarter valued at about $1,279,000. Finally, Bank of America Corp DE acquired a new stake in Neonc Technologies during the second quarter worth about $801,000.

Neonc Technologies Company Profile

Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing.